Talc Powder Lawsuit Settlements

For decades, millions of people used Johnson’s Baby Powder, Shower to Shower, and other talc-based body powders. Thousands of lawsuits now allege that repeated exposure caused ovarian cancer or mesothelioma and that Johnson & Johnson failed to warn consumers about the risks.

Mesothelioma claims generally allege that cosmetic talc was contaminated with asbestos. Ovarian cancer lawsuits focus largely on women who regularly applied talcum powder for feminine hygiene over many years. Johnson & Johnson denies that its talc products contained asbestos or caused cancer.

This page explains the proposed 2026 talc settlement, the current federal litigation, recent verdicts, potential claim value, and who may still qualify to file a lawsuit.

If you used talcum powder for an extended period and were later diagnosed with ovarian cancer or mesothelioma, call our talc cancer lawyers at 888-322-3010 or request a free case review.

RECENT TALC LAWSUIT NEWS AND UPDATES

August 4, 2026: Johnson & Johnson Proposes $5.5 Billion Ovarian Cancer Settlement

Johnson & Johnson has announced a proposed agreement to resolve approximately 76,000 federal and state lawsuits alleging that talc products caused ovarian cancer. The company has committed at least $5.5 billion to individual claim payments.

The agreement is not final. At least 95% of the remaining ovarian cancer claimants must agree to participate before the settlement becomes effective. Lawyers representing most of the claims have reportedly agreed to support the proposal, but each plaintiff will still need to make an individual decision.

The settlement uses individual claim payments rather than one equal payout for every plaintiff. The full settlement matrix has not been released, so we do not yet know the average payment, the number of compensation tiers, or how individual claims will be scored.

This is the first serious path toward resolving the ovarian cancer litigation after Johnson & Johnson’s three failed bankruptcy attempts. The timing is not accidental. The proposal came shortly after the federal judge raised significant questions about whether plaintiffs could offer admissible expert testimony proving that talc caused each woman’s ovarian cancer.

July 22, 2026: Federal Judge Raises Specific Causation Concerns

U.S. Magistrate Judge Rukhsanah Singh ordered plaintiffs in the federal ovarian cancer litigation to explain why their cases should not be dismissed for lack of admissible specific-causation evidence.

General causation asks whether talc is capable of causing ovarian cancer. Specific causation asks whether talc use caused a particular plaintiff’s disease. That second issue became a serious problem after two plaintiff experts withdrew from selected bellwether cases and gave testimony that raised questions about whether they could reliably identify talc as the cause of an individual woman’s cancer.

The lawsuits have not been dismissed. Plaintiffs have an opportunity to identify additional expert evidence and respond to the court’s concerns. But the order created real risk for ovarian cancer plaintiffs and likely accelerated the settlement negotiations.

June 5, 2026: Johnson & Johnson Wins Los Angeles Ovarian Cancer Trial

A Los Angeles jury returned a defense verdict in a consolidated lawsuit brought by the families of Mary Owens, Bonnie Tienken, and Geneva Williams. The families alleged that long-term use of Johnson & Johnson talc products caused the women’s ovarian cancer.

The verdict was disappointing for plaintiffs and gave Johnson & Johnson leverage in settlement negotiations. It followed a $40 million plaintiff verdict in the first trial from the same coordinated California proceeding, showing how differently juries can evaluate similar talc claims.

February 13, 2026: Philadelphia Jury Awards $250,000 in Ovarian Cancer Case

A Philadelphia jury awarded $250,000 to the family of Gayle Emerson, who used Johnson & Johnson talc products for nearly five decades before developing ovarian cancer.

The award included $50,000 in compensatory damages and $200,000 in punitive damages. The amount was modest compared with several other talc verdicts, but the jury still found Johnson & Johnson liable for product defect, negligence, and failure to warn. Johnson & Johnson said it would appeal.

December 22, 2025: $1.5 Billion Punitive Damage Verdict

On December 22, 2025, a Baltimore City jury delivered a unanimous verdict against Johnson & Johnson, awarding more than $1.5 billion in damages to Cherie Craft.

Ms. Craft alleged that years of using Johnson & Johnson baby powder exposed her to asbestos and caused peritoneal mesothelioma. The jury awarded approximately $59.84 million in compensatory damages and $1.5 billion in punitive damages. Johnson & Johnson has said it will appeal.

December 19, 2025: $65.5 Million Minnesota Mesothelioma Verdict

A Minnesota jury awarded $65.5 million to Anna Jean Houghton Carley, a 37-year-old mother diagnosed with mesothelioma. Her lawyers alleged that asbestos in Johnson’s Baby Powder caused her cancer. Johnson & Johnson announced plans to appeal.

December 12, 2025: $40 Million Los Angeles Ovarian Cancer Verdict

A Los Angeles jury awarded $18 million to Monica Kent and $22 million to Deborah Schultz and her husband. Both women alleged that decades of using talc-based baby powder caused ovarian cancer. Johnson & Johnson said it would appeal.

July 1, 2025: Talc MDL Hits 62,123 Cases in Post-Bankruptcy Filing Boom

As of July 1, 2025, the talcum powder MDL in New Jersey had reached 62,123 active cases. That represented 1,331 new filings in one month and continued the sharp increase that followed the collapse of Johnson & Johnson’s third bankruptcy effort.

The litigation has continued growing since then. The August 3, 2026 JPML report now lists 68,914 pending actions in the federal MDL.

June 2, 2025: Bankruptcy Plan Collapses and Federal Litigation Resumes

Johnson & Johnson’s latest attempt to resolve the talc litigation through bankruptcy protection collapsed in 2025, taking the proposed $8.9 billion bankruptcy settlement with it. The dismissal returned the federal lawsuits to active litigation and reopened discovery, expert challenges, and trial preparation.

April 11, 2025: Talc MDL Resumes After Bankruptcy Dismissal

After the third bankruptcy attempt failed, the federal MDL resumed proceedings involving expert testimony, deficient claims, discovery, and bellwether trial planning. Those proceedings eventually led to the July 2026 specific-causation order and the proposed $5.5 billion settlement.

Talcum Powder

Talc is a naturally occurring mineral composed primarily of magnesium, silicon, and oxygen. It is soft, absorbs moisture, and reduces friction, which made it a common ingredient in baby powder, body powder, cosmetics, and industrial products.

Johnson’s Baby Powder was one of the best-known talc products in the United States. Johnson & Johnson stopped selling talc-based baby powder in the United States and Canada in 2020 and discontinued it worldwide in 2023. The company now sells a cornstarch-based version.

Talc Products Linked to Cancer

Talc and asbestos can occur near one another in mineral deposits. The mesothelioma lawsuits allege that talc used in consumer powders was contaminated with asbestos and that repeated inhalation or personal use exposed consumers to dangerous fibers.

Mesothelioma is a rare cancer strongly associated with asbestos exposure. Plaintiffs in these cases generally rely on pathology evidence, mineral testing, exposure histories, corporate records, and expert testimony to connect a particular talc product to the disease.

Ovarian cancer plaintiffs typically allege that they regularly applied talcum powder to the genital area for years or decades. Their lawsuits contend that talc particles could migrate through the reproductive tract and cause inflammation or other biological changes that contributed to cancer.

Johnson & Johnson disputes that theory and argues that the epidemiology does not prove that talc causes ovarian cancer. The scientific debate over specific causation became central to the federal court’s July 2026 order and helped push the parties toward the proposed settlement.

Talcum Powder Class Action Lawsuit

The federal Johnson & Johnson talcum powder lawsuits are consolidated in MDL No. 2738 in the District of New Jersey before U.S. District Judge Michael Shipp.

An MDL is not a class action. Each plaintiff has an individual lawsuit, but common discovery, expert challenges, and pretrial proceedings are coordinated before one judge.

As of August 3, 2026, the JPML listed 68,914 pending actions and 71,601 total actions filed over the life of the litigation. This makes the talc MDL the largest active federal mass tort in the country.

The federal docket is dominated by ovarian cancer claims. Mesothelioma lawsuits have often been filed individually in state courts because they involve different exposure evidence, medical evidence, and defendants.

How the Proposed Talc Settlement Would Work

Johnson & Johnson says the proposed agreement uses per-claim payments and includes at least $5.5 billion for qualifying ovarian cancer claims. The company could ultimately pay more depending on participation and the agreement’s final administration.

The publicly released information does not disclose the exact settlement tiers or the amount assigned to each qualifying claim. Dividing $5.5 billion by the number of plaintiffs will not produce an accurate average because claim values may differ and administrative costs, liens, fees, eligibility decisions, and individual circumstances will affect final payments.

Talcum Powder Verdicts

Since the talcum powder lawsuits first began, numerous cases have gone to trial. Plaintiffs have won several major verdicts, but Johnson & Johnson has also obtained defense verdicts, and some large awards have later been reduced or overturned. Below is a summary of notable talcum powder verdicts:

Potential Talcum Powder Settlement Value

There is no reliable average talcum powder settlement. The proposed ovarian cancer agreement has not disclosed its complete payment matrix, and mesothelioma claims have generally been negotiated separately.

Factors likely to affect an individual claim include:

• Type of cancer: Mesothelioma and ovarian cancer claims involve different scientific and exposure evidence.
• Length and frequency of use: Decades of regular use are generally stronger than occasional exposure.
• Product identification: Receipts are rarely available, but photographs, family testimony, employment records, and consistent use histories can help identify the product.
• Medical evidence: Diagnosis records, pathology reports, treatment history, prognosis, and expert testimony affect value.
• Alternative exposures: Other possible asbestos exposure or competing ovarian cancer risk factors can become major defense issues.
• Age and damages: Medical expenses, lost income, care needs, pain and suffering, and loss of life expectancy affect the compensation amount.
• Settlement eligibility: Ovarian cancer claimants must satisfy the final agreement’s eligibility rules to receive a payment under the proposed program.

Who Is Eligible to File a Talcum Powder Lawsuit?

You may have a potential claim if you were diagnosed with ovarian cancer or mesothelioma after regular exposure to a talc-based consumer product. Families may also be able to file wrongful death claims when a loved one died from one of these cancers.

A lawyer will generally want to know:

• The specific cancer diagnosis and date of diagnosis.
• The talc products used or encountered.
• How frequently and for how many years the products were used.
• How and where the powder was applied.
• Whether there were any occupational or household asbestos exposures.
• The state where the exposure and diagnosis occurred.

You do not need an old bottle or purchase receipt before contacting a lawyer. Many people used the same household products for decades without keeping packaging or records. Family testimony, photographs, medical histories, and other evidence may help establish use.

Deadline for Filing a Talc Lawsuit

State laws differ. The deadline may begin when the cancer was diagnosed, when the person reasonably connected the disease to talc exposure, or when the patient died. Wrongful death claims often have a separate filing period.

The proposed settlement may also impose participation and documentation deadlines that are different from the statute of limitations. Do not assume that the settlement announcement gives you more time to file.

If you have already filed a claim, speak with your current lawyer about settlement eligibility and deadlines. If you have not filed, get your diagnosis and exposure history reviewed promptly.